Alembic Pharmaceuticals reports 68% fall in Q3 consolidated net profit

25 Jan 2017 Evaluate

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2016. 

The company has reported 50.58% fall in its net profit at Rs 137.83 crore for the quarter under review as compared to Rs 278.92 crore for the same quarter in the previous year. Total income of the company decreased by 11.51% at Rs 804.99 crore for the quarter under review as compared Rs 909.65 crore for the corresponding quarter previous year.    

On the consolidated basis, the company has reported 67.81% fall in its net profit after taxes, Minority Interest and Share of Profit / (Loss) of Associates at Rs 86.55 crore for the quarter ended December 31, 2016 as compared to Rs 268.87 crore for the same quarter in the previous year. Total Income of the company decreased by 16.76% to Rs 777.19 crore for quarter under review from Rs 933.69 crore for the quarter ended December 31, 2015.  


Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×